Promoting Safer Sex in HIV+ Homosexual and Bisexual Men Who Use Methamphetamine

This study has been completed.
Sponsor:
Collaborator:
Information provided by:
University of California, San Diego
ClinicalTrials.gov Identifier:
NCT00291512
First received: February 10, 2006
Last updated: October 12, 2011
Last verified: November 2008
  Purpose

This project studies the effectiveness of a sexual risk reduction intervention among HIV+ Men who have Sex with Men (MSM) and who use methamphetamine.


Condition Intervention Phase
HIV Infections
STDs
Methamphetamine Abuse
Behavioral: Theory-based counseling program
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Promoting Safer Sex in HIV+ MSM Methamphetamine Users

Resource links provided by NLM:


Further study details as provided by University of California, San Diego:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • HIV+
  • Men who have sex with men

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00291512

Locations
United States, California
HIV Neurobehavioral Research Center
San Diego, California, United States, 92103
Sponsors and Collaborators
University of California, San Diego
Investigators
Principal Investigator: Thomas L. Patterson, Ph.D. University of California, San Diego
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00291512     History of Changes
Other Study ID Numbers: DESPR DA012116, R01DA012116
Study First Received: February 10, 2006
Last Updated: October 12, 2011
Health Authority: United States: Federal Government

Keywords provided by University of California, San Diego:
HIV
STDs
Methamphetamine abuse
MSM

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Sexually Transmitted Diseases
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Sexually Transmitted Diseases, Viral
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases
Infection
Genital Diseases, Male
Genital Diseases, Female
Methamphetamine
Central Nervous System Stimulants
Physiological Effects of Drugs
Pharmacologic Actions
Central Nervous System Agents
Therapeutic Uses
Sympathomimetics
Autonomic Agents
Peripheral Nervous System Agents
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Dopamine Uptake Inhibitors

ClinicalTrials.gov processed this record on August 21, 2014